These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 19359046)

  • 21. Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.
    Bobes J; Fillat O; Arango C
    Acta Psychiatr Scand; 2009 Mar; 119(3):218-25. PubMed ID: 19178395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test.
    Midorikawa A; Hashimoto R; Noguchi H; Saitoh O; Kunugi H; Nakamura K
    Psychiatry Res; 2008 Jun; 159(3):281-9. PubMed ID: 18448171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of effort, cognitive expectancy appraisals and coping style in the maintenance of the negative symptoms of schizophrenia.
    Avery R; Startup M; Calabria K
    Psychiatry Res; 2009 May; 167(1-2):36-46. PubMed ID: 19339056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological and activity of daily living script performance in patients with positive or negative schizophrenia.
    Godbout L; Limoges F; Allard I; Braun CM; Stip E
    Compr Psychiatry; 2007; 48(3):293-302. PubMed ID: 17445526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The causal model of insight in schizophrenia based on the Positive and Negative Syndrome Scale factors and the structural equation modeling.
    Hwang SS; Chang JS; Lee KY; Ahn YM; Kim YS
    J Nerv Ment Dis; 2009 Feb; 197(2):79-84. PubMed ID: 19214041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sensitivity and specificity of the Overt Aggression Scale in schizophrenic patients].
    Fresán A; Apiquian R; de la Fuente-Sandoval C; García-Anaya M; Nicolini H
    Actas Esp Psiquiatr; 2004; 32(2):71-5. PubMed ID: 15042466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia.
    Strous RD; Ritsner MS; Adler S; Ratner Y; Maayan R; Kotler M; Lachman H; Weizman A
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):14-22. PubMed ID: 18824331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cognitive functions in prepsychotic and negative-symptom schizophrenic patients].
    Ferencz A; Bartók E; Berecz R; Glaub T; Degrell I
    Neuropsychopharmacol Hung; 2005 Jun; 7(2):61-5. PubMed ID: 16167456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive function in schizophrenia: association with negative and positive symptoms.
    Capleton RA
    Psychol Rep; 1996 Feb; 78(1):123-8. PubMed ID: 8839306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding clinical anger and violence: the anger avoidance model.
    Gardner FL; Moore ZE
    Behav Modif; 2008 Nov; 32(6):897-912. PubMed ID: 18614696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moderators and mediators of the stress-aggression relationship: executive function and state anger.
    Sprague J; Verona E; Kalkhoff W; Kilmer A
    Emotion; 2011 Feb; 11(1):61-73. PubMed ID: 21401226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is lack of insight associated with physically aggressive behavior among people with schizophrenia living in the community?
    Lincoln TM; Hodgins S
    J Nerv Ment Dis; 2008 Jan; 196(1):62-6. PubMed ID: 18195643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome.
    Martínez-Arán A; Penadés R; Vieta E; Colom F; Reinares M; Benabarre A; Salamero M; Gastó C
    Psychother Psychosom; 2002; 71(1):39-46. PubMed ID: 11740167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anger and functioning amongst inpatients with schizophrenia or schizoaffective disorder living in a therapeutic community.
    Fassino S; Amianto F; Gastaldo L; Leombruni P
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):186-94. PubMed ID: 19335389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relation between cognitive deficits and schizophrenic symptoms].
    Kukla F
    Z Psychol Z Angew Psychol; 1992; 200(1):37-44. PubMed ID: 1351695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Language disorders and cognitive functions in persons with schizophrenic disorders].
    Waszkiewicz J; Wciórka J; Anczewska M; Chrostek A; Switaj P
    Psychiatr Pol; 2012; 46(4):553-70. PubMed ID: 23214159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of awareness of illness in schizophrenia spectrum disorder with social cognition and cognitive perceptual organization.
    Lysaker PH; Daroyanni P; Ringer JM; Beattie NL; Strasburger AM; Davis LW
    J Nerv Ment Dis; 2007 Jul; 195(7):618-21. PubMed ID: 17632254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Learning potential and cognitive remediation in schizophrenia].
    Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
    Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schizophrenia and hospitalization.
    Ali W
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):223-6. PubMed ID: 16542606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subjective experiences and the psychopathological dimensions in schizophrenia.
    Yon V; Loas G; Brien D
    Psychiatry Res; 2005 Nov; 137(1-2):93-102. PubMed ID: 16213596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.